Drug Information

Drug General Information
Drug ID
D02WSA
Former ID
DNC006396
Drug Name
5,7-dihydroxy-3-phenyl-3H-quinazolin-4-one
Drug Type
Small molecular drug
Indication Discovery agent Investigative [528131]
Formula
C14H10N2O3
Canonical SMILES
C1=CC=C(C=C1)N2C=NC3=CC(=CC(=C3C2=O)O)O
InChI
1S/C14H10N2O3/c17-10-6-11-13(12(18)7-10)14(19)16(8-15-11)9-4-2-1-3-5-9/h1-8,17-18H
InChIKey
LUBZIRZXRMLBKH-UHFFFAOYSA-N
PubChem Compound ID
11579722
Target and Pathway
Target(s) Estrogen receptor beta Target Info Inhibitor [528131]
KEGG Pathway Estrogen signaling pathway
Prolactin signaling pathway
Pathway Interaction Database Plasma membrane estrogen receptor signaling
Validated nuclear estrogen receptor beta network
Validated nuclear estrogen receptor alpha network
Reactome Nuclear Receptor transcription pathway
WikiPathways SIDS Susceptibility Pathways
Ovarian Infertility Genes
Integrated Pancreatic Cancer Pathway
Nuclear Receptors
References
Ref 528131J Med Chem. 2006 Apr 20;49(8):2440-55.Synthesis and characterization of 3-arylquinazolinone and 3-arylquinazolinethione derivatives as selective estrogen receptor beta modulators.
Ref 528131J Med Chem. 2006 Apr 20;49(8):2440-55.Synthesis and characterization of 3-arylquinazolinone and 3-arylquinazolinethione derivatives as selective estrogen receptor beta modulators.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.